Twist Bioscience officer sells shares worth $347,305
Finn Patrick John of Twist Bioscience sold 2,565 shares valued at $347,305, reflecting ongoing executive stock transactions in the biological products sector.
GS Finance Corp. Announces $2.39M in S&P 500 Index-Linked Notes
GS Finance Corp. files for $2.39 million in S&P 500 index-linked notes due 2031, signaling a strategic move in the security brokers and dealers sector.
GS Finance Corp. files for $724,000 in index-linked notes
GS Finance Corp. has filed a registration statement for $724,000 in leveraged index-linked notes due 2031, guaranteed by Goldman Sachs Group.
Timeplast, Inc. seeks $30.78 million in updated stock offering
Timeplast, Inc. files to raise up to $30.78 million through a stock offering, signaling growth ambitions in the plastics industry.
BNY Mellon Research Growth Fund Reports Semi-Annual Results
BNY Mellon Research Growth Fund, Inc. releases its semi-annual report, detailing financial performance and significant portfolio holdings.
Serval Inc. Announces $150 Million Securities Offering
Serval Inc. files for a $150 million securities offering, nearing completion with strong investor interest. A significant move for the tech sector.
JPMorgan Chase Financial Co. files for Step-Up Auto Callable Notes
JPMorgan Chase Financial Co. LLC files a preliminary pricing supplement for Step-Up Auto Callable Notes, guaranteed by JPMorgan Chase & Co.
Morgan Stanley Finance LLC Files Pricing Supplement for Notes
Morgan Stanley Finance LLC has filed a pricing supplement for market-linked notes due in 2030, reflecting its strategy in the competitive financial industry.
Barclays Bank unveils new contingent coupon notes
Barclays Bank PLC has filed for new Autocallable Buffered Contingent Coupon Notes, signaling innovation in structured finance products.
JPMorgan Chase Financial Co. files for new structured notes
JPMorgan Chase Financial Co. LLC files a preliminary pricing supplement for new structured investment notes, signaling innovation in the banking sector.
Twist Bioscience Officer Files to Sell Shares Amid Activity
Robert F. Werner of Twist Bioscience Corp files to sell shares, reflecting ongoing insider trading activity in the biotechnology sector.
Morgan Stanley Finance LLC Files Pricing Supplement for New Investment
Morgan Stanley Finance LLC has filed a pricing supplement for a new structured investment product, reflecting its commitment to innovative financial solutions.
JPMorgan Chase Financial Co. launches new Digital Equity Notes
JPMorgan Chase Financial Co. LLC has filed a pricing supplement for Digital Equity Notes linked to the TOPIX Index, reflecting innovation in the banking sector.
Wooldridge reports acquisition of shares in UFP Industries
Michael G. Wooldridge discloses acquisition of 406 shares in UFP Industries Inc., bringing total holdings to 16,189 shares as of November 2, 2026.
Henry Schein reports Q3 results with continued growth
Henry Schein Inc. reports strong Q3 results, reflecting growth in the wholesale medical, dental, and hospital equipment sector amid ongoing challenges.
SPDR Series Trust Updates Investment Strategies in New Filing
SPDR Series Trust updates its investment strategies and fund offerings in a recent filing, reflecting changes in market conditions and investor needs.
JPMorgan Chase Financial Co. files pricing supplement for notes
JPMorgan Chase Financial Co. LLC files a pricing supplement for $14.76 million in structured investments, signaling growth in the banking sector.
AuguStar Variable Account A Announces Portfolio Reorganizations
AuguStar Variable Account A has approved three reorganizations for its variable annuity contracts, aiming to optimize portfolio offerings and expenses.
Lear Corp officer Jason M. Cardew files to sell 5,000 shares
Jason M. Cardew of Lear Corp has filed to sell 5,000 shares of common stock, valued at approximately $588,736.09, following recent stock vesting.
Barclays Bank unveils callable contingent coupon notes
Barclays Bank PLC has announced a new offering of callable contingent coupon notes due November 14, 2031, enhancing its capital strategy.